![]() |
Cidofovir
Class: Viral DNA polymerase inhibitor
Status: Under testing, emergency use possible
Target: Viral DNA polymerase Brincidofovir (Tembexa)
Class: Viral DNA polymerase inhibitor
Status: Approved (FDA 2021)
Target: Viral DNA polymerase Tecovirimat (ST-256)
Class: viral phospholipase inhibitor |
Sources: CDC Smallpox Prevention and Treatment